Codiak BioSciences, Inc. Deferred Tax Liabilities, Deferred Expense

Codiak BioSciences, Inc. Deferred Tax Liabilities, Deferred Expense

Codiak BioSciences, Inc. had Deferred Tax Liabilities, Deferred Expense of $3.17 million as of 2021-12-31, per its 10-K filed 2022-03-10.

Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities

us-gaap:DeferredTaxLiabilitiesDeferredExpense · last filed 2022-03-10

• 2021-12-31: Deferred Tax Liabilities, Deferred Expense $3.17M.
• 2020-12-31: Deferred Tax Liabilities, Deferred Expense $3.52M.
• 2019-12-31: Deferred Tax Liabilities, Deferred Expense $1.90M.